Competitive Problems in the Drug Industry : Psychotropic Drugs.

CRS report, prepared by consultant Stephanie Forbes, summarizing, analyzing, and updating 1969-77 Subcom on Monopoly and Anticompetitive Activities hearings (topical index, p. 41-45) on issues surrounding public use of prescription and over-the-counter (OTC) drugs. Examines health hazards and benefi...

Full description

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 1979-1980.
Series:	U.S. Congressional Research.
Subjects:	Advertising. Consumer protection. Drug abuse. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	CRS report, prepared by consultant Stephanie Forbes, summarizing, analyzing, and updating 1969-77 Subcom on Monopoly and Anticompetitive Activities hearings (topical index, p. 41-45) on issues surrounding public use of prescription and over-the-counter (OTC) drugs. Examines health hazards and benefits of the so-called mood drugs, societal and public policy implications and responsibilities, the effect of advertising and promotion on drug use, and related FCC, FTC, and FDA initiatives. Appendices (p. 39-112) include lists of currently available psychotropic and OTC drugs (p. 46-52) and "Over-the-Counter Nighttime Sleep-Aid and Stimulant Products," FDA Tentative Final Orders, Fed Register, June 13, 1978 (p. 53-112).
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.